跳至主要内容
临床试验/CTRI/2021/01/030806
CTRI/2021/01/030806招募中不适用

Role of CRP/albumin ratio in acute pancreatitis

Kasturba medical college Manipal1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年1月31日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
62
试验地点
1
主要终点
Reliability of CRP/albumin ratio in predicting the severity, morbidity and mortality in acute pancreatitis

研究概览

简要总结

It is a prospective observational study. Patients who will be diagnosed with acute pancreatitis and satisfying the criteria will be included. Standard data will be collected during patients admissions as a part of routine clinical practice. Data will be extracted from this data base. CRP/albumin ratio will be calculated and compared with other routine investigations that are routinely used in cases of pancreatitis (isolated CRP, hematocrit, Glasgow imrie score, BMI, CT severity) in assessing the severity and prognosis of the disease.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with acute pancreatitis.

排除标准

  • Pregnancy 2) Patients with chronic liver disease 3) Recurrent/chronic pancreatitis.

结局指标

主要结局

Reliability of CRP/albumin ratio in predicting the severity, morbidity and mortality in acute pancreatitis

时间窗: 10 days

次要结局

  • Efficacy of crp/albumin ratio in predicting prognosis of acute pancreatitis compared to routinely used other investigations(10 days)

研究者

申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验